Vitalidade de Indianápolis

BioCrossroads Drives Collaboration and Growth in Indiana’s Life Sciences Sector

Since 2002, BioCrossroads has worked to catalyze innovation and collaboration within Indiana’s life sciences sector. The sector has grown at a remarkable pace and has generated billions of dollars in revenue for the state with $79 billion in economic impact in 2021. BioCrossroads plays a critical role by convening academic, philanthropic, and cross-sector employer partners, enhancing research development, and working to attract life sciences businesses, innovation, and talent to Indiana.  

This unique collaborative approach has proven to be successful in times of need. At the onset of the COVID-19 pandemic, BioCrossroads played a key role convening Indiana’s life science and healthcare partners troubleshoot COVID testing, vaccine development and deployment, and other needs for Indiana residents.  

The Richard M. Fairbanks Foundation has awarded $11.5 million to BioCrossroads since 2003 to advance the economic vitality of Indianapolis. 

Additional Posts

Saúde

The FDA Plans to Limit Nicotine in Cigarettes—Will That Lower Smoking Rates?

Alex Cohen is the Director of Learning and Evaluation for the Richard M. Fairbanks Foundation. The dangers of smoking are well-known. Smokers are more likely to die from lung cancer, heart disease, lung disease and other deadly illnesses, not to mention the health risks caused by secondhand smoke exposure or the impacts to newborns caused […]

READ MORE
Saúde

Shedding Light on Indiana’s “Forgotten” Tobacco Epidemic

Claire Fiddian-Green is the President & CEO of the Richard M. Fairbanks Foundation. In Indianapolis, tobacco retail outlets are concentrated in areas with high poverty, low levels of education, and high levels of poor mental health. These are also the areas where smoking rates are higher, on average and among pregnant women specifically. These are […]

READ MORE